ASTH - Astrana Health, Inc.

Astrana Health: 81% Full-Risk And Profitable

Astrana Health is rated a buy, trading at a 46% discount to peers despite sector-wide reserve releases clarifying earnings quality concerns. ASTH's Care Enablement platform drove G&A costs from 7.75% to 5.57% of revenue, quadrupling third-party revenue year-over-year and supporting durable profit at scale. Organic growth is driven by a mix-shift into full-risk capitation, with management projecting ongoing revenue-per-member expansion and a robust conversion pipeline.

Aug 12, 2026 07:00 AM • seekingalpha.com

Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript

Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript

Aug 06, 2026 08:34 PM • seekingalpha.com

Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates

Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.19 per share a year ago.

Aug 06, 2026 04:12 PM • zacks.com

Astrana Health Q2 Earnings Call Highlights

Astrana Health NASDAQ: ASTH reported second-quarter 2026 revenue of $973 million, up 49% from a year earlier, while adjusted EBITDA increased 43% to $69 million. Adjusted diluted earnings per share reached a record $0.80, up 45% year over year, as the company cited growth in value-based care arrangements, medical-cost management, Prospect Health acquisition synergies and operating leverage.

Aug 06, 2026 03:04 PM • marketbeat.com

Astrana Health, Inc. Reports Second Quarter 2026 Results

Company to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m.

Aug 06, 2026 12:05 PM • prnewswire.com

A Look at Astrana Health Inc (ASTH) After 3.0% Decline -- GF Value $83.77 vs Price $35.52

On July 31, 2026, Astrana Health Inc (ASTH) shares fell 3.0% to a current price of $35.52. The stock has seen significant volatility, with a 52-week range of $1

Jul 31, 2026 03:51 PM • gurufocus.com

Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call

ALHAMBRA, Calif., July 14, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2026, after the close of the stock market on Thursday, August 6, 2026.

Jul 14, 2026 12:30 PM • prnewswire.com

Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth

Names Daniel Rothman President of Physician Enterprise and Vishal Gupta Senior Vice President of Enterprise Transformation ALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced the appointments of Daniel Rothman as President of Physician Enterprise and Vishal Gupta as Senior Vice President of Enterprise Transformation.

Jul 13, 2026 12:30 PM • prnewswire.com

Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year

All Eight ACOs Achieve Net Shared Savings ALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that its Accountable Care Organizations (ACOs) generated $120.4 million in gross shared savings during the 2024 performance year.

Jul 13, 2026 04:00 AM • prnewswire.com

Astrana Health, Inc. (ASTH) Surges 7.3%: Is This an Indication of Further Gains?

Astrana Health, Inc. (ASTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Jul 02, 2026 07:21 AM • zacks.com

Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth

ALHAMBRA, Calif., June 4, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced it has been named to the Fortune 1000® for 2026, marking its debut on the annual ranking of the largest U.S. companies by revenue.

Jun 04, 2026 01:00 PM • prnewswire.com

Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations

Astrana Health NASDAQ: ASTH CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected first-quarter trends across medical costs, free cash flow and revenue.

May 12, 2026 07:07 PM • marketbeat.com

Astrana Health, Inc. (ASTH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Astrana Health, Inc. (ASTH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

May 12, 2026 05:40 PM • seekingalpha.com

Astrana Health, Inc. Announces Appointment of Interim National Medical Director

ALHAMBRA, Calif., May 12, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced the appointment of George Christides, M.D.

May 12, 2026 12:05 PM • prnewswire.com

Physician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary Care

Expands access to Astrana's Medicare ACO platform, powered by a unified AI-powered platform designed for independent physicians ALHAMBRA, Calif., May 11, 2026 /PRNewswire/ -- The Physician Association of California ("PAC") and Astrana Health, Inc. ("Astrana") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced a collaboration to help independent primary care physicians remain independent – and succeed – in an increasingly complex healthcare system while improving patient care.

May 11, 2026 12:05 PM • prnewswire.com

Astrana Health, Inc. (ASTH) Q1 2026 Earnings Call Transcript

Astrana Health, Inc. (ASTH) Q1 2026 Earnings Call Transcript

May 07, 2026 11:51 PM • seekingalpha.com

Astrana Health, Inc. (ASTH) Surpasses Q1 Earnings and Revenue Estimates

Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.14 per share a year ago.

May 07, 2026 02:55 PM • zacks.com

Astrana Health, Inc. Reports First Quarter 2026 Results

Company to Host Conference Call on Thursday, May 7, 2026, at 2:30 p.m. PT/5:30 p.m.

May 07, 2026 12:05 PM • prnewswire.com

Is the Options Market Predicting a Spike in Astrana Health Stock?

Investors need to pay close attention to ASTH stock based on the movements in the options market lately.

Apr 22, 2026 08:20 AM • zacks.com

Astrana Health, Inc. Schedules 2026 First Quarter Financial Results Release and Conference Call

ALHAMBRA, Calif., April 21, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2026, after the close of the stock market on Thursday, May 7, 2026.

Apr 21, 2026 04:00 AM • prnewswire.com

Astrana Health price target raised to $55 from $47 at Truist

$55.00 (was $37.47)

Truist Financial

Aug 10, 2026 03:57 PM • TheFly

Astrana Health price target raised to $53 from $50 at Barclays

$53.00 (was $34.13)

Barclays

Aug 07, 2026 05:28 AM • TheFly

Astrana Health price target raised to $65 from $50 at BTIG

$65.00 (was $47.64)

David Larsen · BTIG

Jul 14, 2026 07:04 AM • TheFly

Astrana Health upgraded to Overweight from Equal Weight at Barclays

$50.00 (was $39.00)

Barclays

May 26, 2026 08:54 AM • TheFly

Astrana Health price target raised to $47 from $38 at Truist

$47.00 (was $39.39)

Truist Financial

May 14, 2026 09:25 AM • TheFly

Astrana Health price target raised to $37 from $26 at Barclays

$37.00 (was $39.30)

Barclays

May 11, 2026 05:21 AM • TheFly

Astrana Health price target raised to $41 from $30 at Needham

$41.00 (was $37.90)

Matthew Shea · Needham

May 08, 2026 09:53 AM • TheFly

Astrana Health price target raised to $45 from $40 at Baird

$45.00 (was $36.03)

Robert W. Baird

May 08, 2026 08:43 AM • TheFly

Astrana Health price target raised to $40 from $37 at Baird

$40.00 (was $29.07)

Robert W. Baird

Apr 15, 2026 06:18 AM • TheFly

Astrana Health price target lowered to $40 from $45 at BTIG

$40.00 (was $22.74)

BTIG

Feb 02, 2026 07:14 AM • TheFly

Astrana Health initiated with a Buy at Needham

$28.00 (was $22.46)

Matthew Shea · Needham

Dec 12, 2025 06:23 AM • TheFly

Astrana Health price target lowered to $37 from $44 at Jefferies

$37.00 (was $22.91)

Jefferies

Nov 25, 2025 11:33 AM • TheFly

Astrana Health price target lowered to $26 from $36 at Barclays

$26.00 (was $22.50)

Andrew Mok · Barclays

Nov 24, 2025 06:21 AM • TheFly

Astrana Health initiated with an Equal Weight at Barclays

$36.00 (was $29.86)

Barclays

Apr 01, 2025 07:26 AM • TheFly

Astrana Health price target lowered to $50 from $86 at Baird

$50.00 (was $26.48)

Robert W. Baird

Mar 03, 2025 07:00 AM • TheFly

Astrana Health price target raised to $70 from $60 at BTIG

$70.00 (was $57.87)

David Larsen · BTIG

Oct 03, 2024 03:22 AM • TheFly

Astrana Health price target raised to $67 from $54 at Baird

$67.00 (was $46.58)

Michael Ha · Robert W. Baird

Aug 15, 2024 02:34 AM • TheFly

Astrana Health, Inc (ASTH) PT Raised to $48 at Stifel

$48.00 (was $40.50)

Chris O'Cull · Stifel Nicolaus

Jun 27, 2024 04:09 AM • StreetInsider